Results 61 to 70 of about 121,048 (155)

Impact of Human Papillomavirus Primary Cervical Screening on Referral Rates and Outcomes for People Referred to Colposcopy for Clinical Reasons

open access: yesAustralian and New Zealand Journal of Obstetrics and Gynaecology, Volume 66, Issue 5, October 2026.
ABSTRACT Colposcopy is most commonly indicated for people with screen‐positive cervical screening tests. However, clinical reasons such as post‐coital bleeding (PCB) or an abnormal appearing cervix can also prompt referral. Aotearoa New Zealand (AoNZ) transitioned from a cytology‐based to an HPV‐based cervical screening programme in September 2023 ...
Adibah Khan   +3 more
wiley   +1 more source

Dissociating memory networks in early Alzheimer's disease and frontotemporal lobar degeneration - a combined study of hypometabolism and atrophy [PDF]

open access: yes, 2013
Introduction: We aimed at dissociating the neural correlates of memory disorders in Alzheimer’s disease (AD) and frontotemporal lobar degeneration (FTLD).
Barbara Vogt   +29 more
core   +2 more sources

Ospemifene in the Management of Vulvar and Vaginal Atrophy: Focus on the Assessment of Patient Acceptability and Ease of Use

open access: yesPatient Preference and Adherence, 2020
Angelo Cagnacci, 1 Anjeza Xholli, 2 Martina Venier 2 1Obstetrics and Gynaecology Unit, Obstetrics and Gynaecology University of Genova, Genova, Italy; 2Obstetrics and Gynaecology Unit, Azienda Sanitaria Universitaria Integrata di Udine, Udine ...
Cagnacci A, Xholli A, Venier M
doaj  

Solving a 50 year mystery of a missing OPA1 mutation: more insights from the first family diagnosed with autosomal dominant optic atrophy [PDF]

open access: yes, 2010
Background: Up to the 1950s, there was an ongoing debate about the diversity of hereditary optic neuropathies, in particular as to whether all inherited optic atrophies can be ascribed to Leber's hereditary optic neuropathy (LHON) or represent different ...
Alexander Christiane   +35 more
core   +1 more source

Current approaches to the treatment of vulvovaginal atrophy in women with gynecological and breast cancer

open access: yesФармакоэкономика
Background. Treatment of vulvovaginal atrophy (VVA) in women diagnosed with gynecologic or breast cancer presents challenges. Treatment options for VVA, the genital manifestation of the genitourinary syndrome of menopause (GSM), generally mirror those ...
O. S. Gridasova   +5 more
doaj   +1 more source

Menopausal hormone therapy and comprehensive postmenopausal care in gynecologic cancer survivors: A position paper from the FIGO Committee on Women at Menopausal Age

open access: yesInternational Journal of Gynecology &Obstetrics, Volume 174, Issue 3, Page 1151-1171, September 2026.
Abstract Recent advances in cancer screening, diagnosis, and treatment have greatly improved survival rates among women with gynecologic cancers. More survivors now live long enough to experience treatment‐related menopause. Vasomotor symptoms, genitourinary syndrome of menopause, sexual dysfunction, sleep issues, and long‐term risks from estrogen ...
Agnaldo Lopes da Silva‐Filho   +8 more
wiley   +1 more source

Psychodermatology of the Female: Hormones, Skin and Mental Health Across the Lifespan

open access: yesJEADV Clinical Practice, Volume 5, Issue 3, Page 769-776, September 2026.
Hormonal transitions across the female lifespan shape skin disease and psychiatric comorbidity through the brain–skin axis and Neuro‐Immuno‐Cutaneous‐Endocrine (NICE) network. This narrative review links puberty, menstruation, pregnancy, postpartum and menopause to dermatologic and psychosocial outcomes.
Sheila Sharifi   +4 more
wiley   +1 more source

Experience with ospemifene in patients with vulvar and vaginal atrophy: case studies with bone marker profiles

open access: yesDrugs in Context, 2020
Selective estrogen receptor modulators (SERMs) exhibit varying agonist/antagonist activities on estrogen receptors in tissues, although most SERMs, including ospemifene, have agonist effects on bone.
María del Carmen Pingarrón Santofimia   +3 more
doaj   +1 more source

Early Intervention Effects and Risk Factors for Residual Skin Changes in Infantile Hemangiomas

open access: yesThe Journal of Dermatology, Volume 53, Issue 9, Page 1296-1304, September 2026.
ABSTRACT Infantile hemangioma (IH) characteristically progresses through proliferative, involuting, and involuted phases, and typically undergoes spontaneous regression after the age of five. Therefore, the traditional management strategy has been based on a “wait‐and‐see policy”.
Kayoko Okuda   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy